Merck KGaA (Merck KGaA) Earnings per Share (Diluted)

: $1.40 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Merck KGaA's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.29. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.40.

Merck KGaA's EPS (Basic) for the three months ended in Dec. 2023 was $0.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.40.

Merck KGaA's EPS without NRI for the three months ended in Dec. 2023 was $0.27. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39.

During the past 12 months, Merck KGaA's average EPS without NRIGrowth Rate was -20.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 15.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.90% per year.

During the past 13 years, Merck KGaA's highest 3-Year average EPS without NRI Growth Rate was 48.90% per year. The lowest was -16.70% per year. And the median was 7.50% per year.

Merck KGaA Earnings per Share (Diluted) Historical Data

The historical data trend for Merck KGaA's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

0.68

1.11

1.59

1.62

1.42

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)																0.32	0.39	0.35	0.36	0.29

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's PE Ratio falls into.

Merck KGaA Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Merck KGaA's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(3079.607	-	0)	/	2173.889
	=	1.42

Merck KGaA's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(639.04	-	0)	/	2177.111
	=	0.29

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.40

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Merck KGaA (OTCPK:MKKGY) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Merck KGaA Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.